FI20095563A0 - Vaginal delivery system - Google Patents

Vaginal delivery system

Info

Publication number
FI20095563A0
FI20095563A0 FI20095563A FI20095563A FI20095563A0 FI 20095563 A0 FI20095563 A0 FI 20095563A0 FI 20095563 A FI20095563 A FI 20095563A FI 20095563 A FI20095563 A FI 20095563A FI 20095563 A0 FI20095563 A0 FI 20095563A0
Authority
FI
Finland
Prior art keywords
delivery system
vaginal delivery
vaginal
delivery
Prior art date
Application number
FI20095563A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20095563A (en
Inventor
Christine Talling
Antti Keinaenen
Svante Holmberg
Original Assignee
Bayer Schering Pharma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Oy filed Critical Bayer Schering Pharma Oy
Priority to FI20095563A priority Critical patent/FI20095563A/en
Publication of FI20095563A0 publication Critical patent/FI20095563A0/en
Priority to PCT/FI2010/050388 priority patent/WO2010133757A1/en
Priority to TW099115770A priority patent/TW201043208A/en
Priority to ARP100101718A priority patent/AR076588A1/en
Publication of FI20095563A publication Critical patent/FI20095563A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20095563A 2009-05-20 2009-05-20 Vaginal delivery system FI20095563A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI20095563A FI20095563A (en) 2009-05-20 2009-05-20 Vaginal delivery system
PCT/FI2010/050388 WO2010133757A1 (en) 2009-05-20 2010-05-12 Vaginal delivery system
TW099115770A TW201043208A (en) 2009-05-20 2010-05-18 Vaginal delivery system
ARP100101718A AR076588A1 (en) 2009-05-20 2010-05-18 VAGINAL RELEASE SYSTEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20095563A FI20095563A (en) 2009-05-20 2009-05-20 Vaginal delivery system

Publications (2)

Publication Number Publication Date
FI20095563A0 true FI20095563A0 (en) 2009-05-20
FI20095563A FI20095563A (en) 2010-11-21

Family

ID=40680743

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20095563A FI20095563A (en) 2009-05-20 2009-05-20 Vaginal delivery system

Country Status (4)

Country Link
AR (1) AR076588A1 (en)
FI (1) FI20095563A (en)
TW (1) TW201043208A (en)
WO (1) WO2010133757A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105853445A (en) * 2011-06-06 2016-08-17 橡冠科学研究院 Drug delivery device employing wicking release window
CN108430453B (en) * 2015-12-21 2023-03-17 拜耳股份有限公司 Method of manufacturing a drug delivery device and drug delivery device manufactured according to the method
EP3801462A4 (en) 2018-05-24 2022-03-16 Celanese EVA Performance Polymers LLC Implantable device for sustained release of a macromolecular drug compound
KR20210013089A (en) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 Implantable device for sustained release of macromolecular drug compounds
WO2020123148A1 (en) * 2018-12-11 2020-06-18 Lupin Inc. Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
FI95768C (en) * 1993-06-17 1996-03-25 Leiras Oy Intravaginal dosing system
DE19606355A1 (en) * 1996-02-12 1997-08-14 Schering Ag Contraceptive release systems with antiviral and / or antibacterial effects
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
CN101237851B (en) * 2005-06-16 2013-09-18 沃纳奇尔科特有限责任公司 Estrogen compositions for vaginal administration
CA2612415A1 (en) * 2005-06-16 2006-12-28 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
IE20050723A1 (en) * 2005-10-28 2007-05-30 Patrick T Prendergast Anti-mineralocorticoid therapy of infection
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US20090099149A1 (en) * 2007-10-11 2009-04-16 Wyeth Bioadhesive film
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
ATE508734T1 (en) * 2007-11-22 2011-05-15 Bayer Oy VAGINAL RELEASE SYSTEM
JP2012502988A (en) * 2008-09-16 2012-02-02 プレイテックス プロダクツ エルエルシー Preparations for menstrual suppression, contraception and hormone replacement therapy, and methods of administration thereof
FI121000B (en) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginal delivery system and method for its preparation

Also Published As

Publication number Publication date
WO2010133757A1 (en) 2010-11-25
TW201043208A (en) 2010-12-16
AR076588A1 (en) 2011-06-22
FI20095563A (en) 2010-11-21

Similar Documents

Publication Publication Date Title
FI20095550A0 (en) Vaginal delivery system
DK2398500T3 (en) GLUTATHION-BASED PHARMACEUTICAL DELIVERY SYSTEM
BRPI1014975A2 (en) implant delivery system
BRPI1010279A2 (en) drug delivery device
DK2414011T3 (en) DRUG DELIVERY DEVICES
DK2493532T3 (en) Drug delivery device
DK2440157T3 (en) LENS DELIVERY SYSTEM
DK2283904T3 (en) component System
BRPI1012730A2 (en) drug delivery device
FI20090081A0 (en) Elevator system
GB0903810D0 (en) Delivery system
FI20096003A (en) Intrauterine system
FI20085277A0 (en) Intrauterine system
BRPI1010237A2 (en) drug delivery device
DE102009035941B8 (en) diagnostic system
BR112012000799A2 (en) drug delivery device
DK2437736T3 (en) drug delivery
FIU20090395U0 (en) Electronic document delivery system
DK2301611T3 (en) Drug delivery device
FI20090122A0 (en) Elevator system
FI20095563A0 (en) Vaginal delivery system
FI20090014A (en) Elevator system
BR112012011732A2 (en) intrauterine system
DE102009039391A8 (en) Swabs System
FR2952039B1 (en) REBOUCHABILITY SYSTEM

Legal Events

Date Code Title Description
FA Application withdrawn